DCTH
Delcath Systems (DCTH)
$06
About Delcath Systems (DCTH)
Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.
Details
Daily high
$10.25
Daily low
$9.93
Price at open
$9.93
52 Week High
$18.23
52 Week Low
$8.12
Market cap
355.3M
Dividend yield
0.00%
Volume
339,215
Avg. volume
599,881
P/E ratio
1,169.77
Delcath Systems News
Details
Daily high
$10.25
Daily low
$9.93
Price at open
$9.93
52 Week High
$18.23
52 Week Low
$8.12
Market cap
355.3M
Dividend yield
0.00%
Volume
339,215
Avg. volume
599,881
P/E ratio
1,169.77